March 8, 2018 / 9:19 PM / 2 months ago

BRIEF-Audentes Therapeutics Q4 Loss Per Share ‍$0.82

March 8 (Reuters) - Audentes Therapeutics Inc:

* AUDENTES THERAPEUTICS REPORTS FOURTH QUARTER 2017 AND FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* AUDENTES THERAPEUTICS INC - ‍PLAN TO FILE IND MID-2018 AND INITIATE A PHASE 1/2 CLINICAL TRIAL OF AT982 IN Q4 OF 2018​

* AUDENTES THERAPEUTICS INC QTRLY LOSS PER SHARE ‍$0.82

* AUDENTES THERAPEUTICS INC - ‍CURRENT CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS ARE PLANNED TO FUND OPERATIONS INTO SECOND HALF OF 2020​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below